Results 261 to 270 of about 164,819 (283)

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

open access: yesClinical Pharmacology and Therapeutics, 2014
L. Ramsey   +15 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy

Journal of Neurology Neurosurgery & Psychiatry, 2016
Yurika Watanabe   +7 more
semanticscholar   +1 more source

Statin-Associated Autoimmune Myopathy.

New England Journal of Medicine, 2016
A. Mammen
semanticscholar   +1 more source

Statin-associated autoimmune myopathy.

Rheumatology, 2017
Tasneam Shagroni   +3 more
semanticscholar   +1 more source

Association between SLCO1B1 T521C polymorphism and risk of statin-induced myopathy: a meta-analysis

The Pharmacogenomics Journal, 2018
Q. Xiang   +8 more
semanticscholar   +1 more source

Statin-Associated Autoimmune Myopathy: A Systematic Review of 100 Cases

Journal of clinical rheumatology, 2017
Salik Nazir   +4 more
semanticscholar   +1 more source

Mutations in dynamin 2 cause dominant centronuclear myopathy

Nature Genetics, 2005
Marc Bitoun   +2 more
exaly  

Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.

JAMA Neurology, 2015
C. Kassardjian   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy